LungLife AI Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9H4?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,347,653	4.4%
VC/PE Firms	3,642,418	11.9%
General Public	7,399,354	24.1%
Individual Insiders	8,016,857	26.1%
Institutions	10,252,321	33.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.3%.

Top Shareholders

Top 17 shareholders own 75.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.5%	Simon Raab	4,148,293	€450.2k	0%	no data
12.7%	Unicorn Asset Management Ltd.	3,907,142	€424.0k	0%	0.06%
8.06%	Mount Sinai School Of Medicine, Endowment Arm	2,469,842	€268.0k	0%	0.14%
6.42%	Octopus Investments Limited	1,968,750	€213.7k	0%	0.01%
5.46%	Syno Capital	1,673,668	€181.6k	0%	no data
4.99%	Frederick Gluck	1,530,596	€166.1k	0%	no data
4.65%	Stifel Asset Management Corp.	1,424,784	€154.6k	0%	no data
4.55%	Investec Wealth & Investment Limited	1,394,839	€151.4k	0%	no data
4.4%	Bohai Ferry Group Co., Ltd.	1,347,653	€146.2k	0%	no data
4.14%	Lombard Odier	1,268,363	€137.6k	0%	no data
3.11%	Huateng Ma	954,048	€103.5k	0%	no data
2.73%	Killik Asset Management	836,964	€90.8k	0%	0.01%
0.71%	SVM Asset Management Limited	218,750	€23.7k	0%	0.01%
0.14%	Roy Davis	42,775	€4.6k	0%	no data
0.086%	David Anderson	26,408	€2.9k	0%	no data
0.086%	Paul Pagano	26,408	€2.9k	0%	no data
0.065%	Andrew Boteler	19,966	€2.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 19:57
End of Day Share Price	2024/12/23 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LungLife AI, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Adam Barker	Goodbody Stockbrokers
Andrew Whitney	Investec Bank plc (UK)
Jens Lindqvist	Investec Bank plc (UK)